{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:04:16Z","timestamp":1791475456613,"version":"4.3.4"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T00:00:00Z","timestamp":1434931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0127676","type":"journal-article","created":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T14:08:54Z","timestamp":1434982134000},"page":"e0127676","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy"],"prefix":"10.1371","volume":"10","author":[{"given":"Josu\u00e9","family":"Rakotonjanahary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"De Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Delion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Kalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Doz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Leblond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Isabelle","family":"Bertozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Rialland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Brain Tumor Committee of SFCE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,6,22]]},"reference":[{"key":"ref1","first-page":"633","article-title":"Principles and Practice of Pediatric Oncology","author":"RL Heideman","year":"1993"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1586\/ern.09.4","article-title":"Gliomas in patients with neurofibromatosis type 1","volume":"9","author":"AC Albers","year":"2009","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0039-6257(94)90173-2","article-title":"Gliomas of the anterior visual pathway","volume":"38","author":"JJ Dutton","year":"1994","journal-title":"Surv Ophtalmol"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/pbc.20655","article-title":"Optic pathway gliomas","volume":"46","author":"CD Jahraus","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"ref5","first-page":"591","article-title":"Characterization and outcomes of optic nerve gliomas: a population-based analysis J Neuro-oncol","volume":"107","author":"MV Mishra","year":"2012","journal-title":"Characterization and outcomes of optic nerve gliomas: a population-based analysis J Neuro-oncol"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/adc.79.4.334","article-title":"Long term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era","volume":"79","author":"C Capelli","year":"1998","journal-title":"Arch Dis Child"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/modpathol.2013.79","article-title":"Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system","volume":"26","author":"GF Reis","year":"2013","journal-title":"Modern Pathology"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s004310000531","article-title":"When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre","volume":"159","author":"J Grill","year":"2000","journal-title":"Eur J Pediatr"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/bjo.73.12.967","article-title":"Optic nerve glioma and the management of optic nerve tumours in the young","volume":"73","author":"JE Wright","year":"1989","journal-title":"Br J Ophtalmol"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/1097-0142(19900101)65:1<45::AID-CNCR2820650111>3.0.CO;2-Z","article-title":"Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects","volume":"65","author":"SM Pierce","year":"1990","journal-title":"Cancer"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1531-8249(199903)45:3<393::AID-ANA17>3.0.CO;2-B","article-title":"Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma","volume":"45","author":"J Grill","year":"1999","journal-title":"Ann Neurol"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/BF02072067","article-title":"Growth and endocrine disorders in optic glioma","volume":"149","author":"R Brauner","year":"1990","journal-title":"Eur J Pediatr"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1200\/JCO.2003.03.043","article-title":"Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy. Results of the first French prospective study for the French Society of of Pediatric Oncology","volume":"21","author":"V Laithier","year":"2003","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.410230113","article-title":"Treatment of chiasmatic\/hypothalamic gliomas of childhood with chemotherapy: an update","volume":"23","author":"RJ Packer","year":"1988","journal-title":"Ann Neurol"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3171\/jns.1997.86.5.0747","article-title":"Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas","volume":"86","author":"RJ Packer","year":"1997","journal-title":"J Neurosurg"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1005736104205","article-title":"Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen","volume":"32","author":"MD Prados","year":"1997","journal-title":"J Neurooncol"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/neuonc\/2.4.213","article-title":"Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study","volume":"2","author":"DH Mahoney Jr","year":"2000","journal-title":"Neuro Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/pbc.22198","article-title":"Natural history and Outcome of Optic Pathway Gliomas in Children","volume":"53","author":"G Nicolin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"ref19","first-page":"1257","article-title":"A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702) Neuro-Oncology","volume":"12","author":"T Stokland","year":"2010","journal-title":"A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702) Neuro-Oncology"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ana.24157","article-title":"Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma","volume":"75","author":"MJ Fisher","year":"2014","journal-title":"Ann Neurol"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"P Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ejca.2006.02.022","article-title":"Prognostic factors for progression of childhood optic pathway glioma: A systematic review","volume":"42","author":"E Opocher","year":"2006","journal-title":"Europ J of Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/cncr.11119","article-title":"Survival and functional outcome of children with hypothalamic\/ chiasmatic tumors","volume":"97","author":"M Fouladi","year":"2003","journal-title":"Cancer"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/neuonc\/nos202","article-title":"Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology","volume":"14","author":"AK Gnekow","year":"2012","journal-title":"Neuro Oncol"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0360-3016(93)90342-S","article-title":"Optic glioma in children: surveillance, resection, or irradiation?","volume":"25","author":"D Jenkin","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1200\/JCO.2005.03.8349","article-title":"Second primary tumors in neuro-fibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy","volume":"24","author":"S Sharif","year":"2006","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref27","first-page":"331","article-title":"Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy\u2014report from the multicenter treatment study for children and adolescents with a low grade glioma\u2014HIT-LGG 1996\u2014of the Society of Pediatric Oncology and Hematology (GPOH)","volume":"216","author":"AK Gnekow","year":"2004","journal-title":"Klin Padiatr"},{"key":"ref28","first-page":"457","article-title":"Children &lt;1 Year Show an Inferior Outcome When Treated According to the Traditional LGG Treatment Strategy: A Report From the German Multicenter Trial HIT-LGG 1996 for Children With Low Grade Glioma (LGG) Pediatr Blood Cancer","volume":"61","author":"C Mirow","year":"2014","journal-title":"Children <1 Year Show an Inferior Outcome When Treated According to the Traditional LGG Treatment Strategy: A Report From the German Multicenter Trial HIT-LGG 1996 for Children With Low Grade Glioma (LGG) Pediatr Blood Cancer"},{"issue":"8","key":"ref29","first-page":"1499","article-title":"Diencephalic syndrome: clinical features and imaging findings","volume":"18","author":"TY Poussaint","year":"1997","journal-title":"Am J Neuroradiol"},{"key":"ref30","first-page":"195","article-title":"Favorable survival and metabolic outcome for children with diencephalic syndrome using a radiation-sparing approach J Neurooncol","volume":"116","author":"JP Kilday","year":"2014","journal-title":"Favorable survival and metabolic outcome for children with diencephalic syndrome using a radiation-sparing approach J Neurooncol"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/FOC-07\/11\/E2","article-title":"Optic pathway gliomas: a review","volume":"23","author":"MJ Binning","year":"2007","journal-title":"Neurosurg Focus"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/08880010050120818","article-title":"Visual pathway tumors and hydrocephalus","volume":"17","author":"A Shuper","year":"2000","journal-title":"Pediatr Hematol Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3174\/ajnr.A0963","article-title":"Harris G Brain tumor imaging in clinical trials","volume":"29","author":"J Henson","year":"2008","journal-title":"Am J Neuroradiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.WNL.0000049467.54667.92","article-title":"Interobserver variability in the radiological assessment of response to chemotherapy in glioma","volume":"60","author":"MJ Vos","year":"2003","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1172\/JCI33656","article-title":"BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas","volume":"118","author":"S Pfister","year":"2008","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1158\/1078-0432.CCR-11-0034","article-title":"BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric","volume":"17","author":"C Hawkins","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref37","first-page":"2561","article-title":"Pediatric glioma-associated KIAA1549: BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner Genes Dev","volume":"26","author":"A Kaul","year":"2012","journal-title":"Pediatric glioma-associated KIAA1549: BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner Genes Dev"},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/NEN.0b013e3182656ef8","article-title":"BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper","volume":"71","author":"FJ Rodriguez","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref39","first-page":"693","article-title":"Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution Neuropathol Appl Neurobiol","volume":"39","author":"C Colin","year":"2013","journal-title":"Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution Neuropathol Appl Neurobiol"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/0883073813476141","article-title":"Pilocytic astrocytoma: a disease with evolving molecular heterogeneity","volume":"28","author":"Z Sadighi","year":"2013","journal-title":"J Child Neurol"},{"issue":"16","key":"ref41","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/onc.2013.148","article-title":"The molecular and cell biology of pediatric low-grade gliomas","volume":"33","author":"YH Chen","year":"2014","journal-title":"Oncogene"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0127676","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T11:01:21Z","timestamp":1566903681000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0127676"}},"subtitle":[],"editor":[{"given":"Marta M.","family":"Alonso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,22]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0127676","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,22]]}}}